The Emerging Role Of Benfotiamine (Vitamin B1) In Patients With Alcoholism

Join us for the Alliance for Addiction Solutions Monthly educational forum, featuring Richard H. Mann, D.P.M., DABPS ret.

About the Speaker

Dr. Richard H. Mann is an American podiatric physician and surgeon whose

career has spanned more than four decades, with a primary focus on

understanding and treating peripheral neuropathy and disorders of the lower

extremities. He is known for introducing benfotiamine, a breakthrough nutrient for

the treatment of alcoholic and other peripheral neuropathies, into North America

and other regions. Today, his benfotiamine-based treatment protocols are

implemented by thousands of physicians across the United States.

As the Founder and Chief Scientific Officer of Realm Labs, LLC, Dr. Mann leads

the development of clinically focused nutritional formulations aimed at improving

nerve function, preventing limb loss, and addressing neurodegenerative

conditions. His work integrates biochemical research, real-world clinical data, and

applied therapeutics to help clinicians achieve better patient outcomes.

Dr. Mann has lectured nationally and internationally and has written extensively

on peripheral neuropathy, polyneuropathy, diabetic pathobiology, lower-limb

amputation prevention, and neurodegeneration. He is widely sought as a

consultant by clinicians, health systems, and industry partners.

He also authors a respected physician newsletter—read by thousands—which

provides timely, practical insights into neurological disorders of the lower

extremities, diabetes-related complications, and emerging therapeutic strategies.